Ameriprise Financial Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Ameriprise Financial Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $11,248 - $46,600	-40,173 Reduced 55.45%	32,270 $10,000
Q1 2024 May 15, 2024	SELL	$1.06 - $1.67 $13,261 - $20,893	-12,511 Reduced 14.73%	72,443 $84,000
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $427 - $606	-339 Reduced 0.4%	84,954 $143,000
Q3 2023 Nov 14, 2023	SELL	$1.61 - $2.54 $37,622 - $59,354	-23,368 Reduced 21.51%	85,293 $154,000
Q2 2023 Aug 14, 2023	SELL	$1.14 - $1.95 $2,012 - $3,441	-1,765 Reduced 1.6%	108,661 $202,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $22,110 - $40,350	18,425 Added 20.03%	110,426 $146,000
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $17,004 - $36,720	-10,432 Reduced 10.18%	92,001 $155,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $62,582 - $320,626	85,729 Added 513.22%	102,433 $320,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $36,748 - $70,156	16,704 New	16,704 $40,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.